Authors: THOMPSON JA GOLD PJ MARKOWITZ DR BYRD DR LINDGREN CG FEFER A

Citation: Ja. Thompson et al., UPDATED ANALYSIS OF AN OUTPATIENT CHEMOIMMUNOTHERAPY REGIMEN FOR TREATING METASTATIC MELANOMA, The cancer journal from Scientific American, 3, 1997, pp. 29-34

Authors: GOLD PJ THOMPSON JA MARKOWITZ DR NEUMANN S FEFER A

Citation: Pj. Gold et al., METASTATIC RENAL-CELL CARCINOMA - LONG-TERM SURVIVAL AFTER THERAPY WITH HIGH-DOSE CONTINUOUS-INFUSION INTERLEUKIN-2, The cancer journal from Scientific American, 3, 1997, pp. 85-91

Authors: LINDGREN CG THOMPSON JA ROBINSON N KEELER T GOLD PJ FEFER A

Citation: Cg. Lindgren et al., INTERLEUKIN-12 INDUCED CYTOLYTIC ACTIVITY IN LYMPHOCYTES FROM RECIPIENTS OF AUTOLOGOUS AND ALLOGENEIC STEM-CELL TRANSPLANTS, Bone marrow transplantation, 19(9), 1997, pp. 867-873

Authors: THOMPSON JA GOLD PJ FEFER A

Citation: Ja. Thompson et al., OUTPATIENT CHEMOIMMUNOTHERAPY FOR THE TREATMENT OF METASTATIC MELANOMA, Seminars in oncology, 24(1), 1997, pp. 44-48

Authors: GOLD PJ THOMPSON JA LINDGREN C KERN D FEFER A

Citation: Pj. Gold et al., PHASE-I TRIAL OF SUBCUTANEOUS (SC), OUTPATIENT INTERLEUKIN-2 (IL-2) FOR PATIENTS WITH ADVANCED MYCOSIS-FUNGOIDES (MF), Blood, 88(10), 1996, pp. 3493-3493